The cytokines interleukin-3 (IL-3); IL-5, and granulocytemacrophage colony-stimulating factor (GM-CSF) are known to contribute to the proliferation and dfierentiation of eosinophil progenitors. Recently, it was determined that the cellular receptors for these three cytokines share a common j3-chain while having unique a-chains. Thus, there is considerable interest in how these cytokines and their receptors interact in promoting production of eosinophils. We have established a cell line (AML14) from a patient with acute myelogenous leukemia that will consistently exhibit eosinophilic differentiation in suspension in response to IL-3, IL-5, and GM-CSF. Proliferation with only modest differentiative effects was observed in response to a single cytokine. We describe the establishment of a new AML cell line with the unusual capacity to demonstrate terminal differentiation to eosinophils in suspension culture in response to IL-5, IL-3, and GM-CSF. Furthermore, cooperative effects of combinations of these cytokines on the proliferation and eosinophilic differentiation of this cell line can be demonstrated, providing a model for study of the interaction of these cytokines and their receptors.
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The cytokines interleukin-3 (IL-3); IL-5, and granulocytemacrophage colony-stimulating factor (GM-CSF) are known to contribute to the proliferation and dfierentiation of eosinophil progenitors. Recently, it was determined that the cellular receptors for these three cytokines share a common j3-chain while having unique a-chains. Thus, there is considerable interest in how these cytokines and their receptors interact in promoting production of eosinophils. We have established a cell line (AML14) from a patient with acute myelogenous leukemia that will consistently exhibit eosinophilic differentiation in suspension in response to IL-3, IL-5, and GM-CSF. Proliferation with only modest differentiative effects was observed in response to a single cytokine. We describe the establishment of a new AML cell line with the unusual capacity to demonstrate terminal differentiation to eosinophils in suspension culture in response to IL-5, IL-3, and GM-CSF. Furthermore, cooperative effects of combinations of these cytokines on the proliferation and eosinophilic differentiation of this cell line can be demonstrated, providing a model for study of the interaction of these cytokines and their receptors.
MATERIALS AND METHODS

Case Report
A 68-year-old man with a recent diagnosis of FAM M2 acute myelogenous leukemia was transferred to our facility after failure to obtain remission following two cycles of treatment with mitoxantrone and cytosine arabinoside. On arrival, the peripheral white blood cell count was 176,00O/pL, essentially all myeloblasts. A bone marrow aspirate was consistent with M2 acute leukemia, as Auer rods were found and some of the blasts contained azurophilic granules. No obvious eosinophilic differentiation was noted in either the bone marrow or peripheral blood. After initiating appropriate supportive care, treatment was attempted with high-dose cytosine arabinoside, but remission could not be obtained and death occurred shortly afterward. Cytogenetic studies were not performed on fresh leukemic cells. 
Hematopoietic Growth Factors
Immunoaffinity purified recombinant human (rh)IL-5 derived from the murine myeloma cell line, NS-1, was a gift of Dr Satwant Narula, Schering-Plough Research, Bloomfield, NJ. Recombinant human GM-CSF and IL-3 were provided by Drs Christopher Henney and Steven Gillis, respectively, Immunex Corp Seattle, WA.
Establishment of the AMLI 4 Cell Line
Heparinized peripheral blood was obtained following informed consent. The mononuclear fraction was separated by Ficoll hypaque sedimentation (Sigma, St Louis, MO) and was placed in tissue culture flasks at 1 X IO6 cells/mL in RPMI 1640 supplemented with 10% fetal calf serum, 2 mmol/L I-glutamine, I mmol/L sodium pyruvate, and 5 X lo-' mol/L 2-mercaptoethanol. From the outset, the cells proliferated vigorously and maintained >90% viability on serial observations. They have now been maintained for over 15 months in continuous suspension culture, with a current doubling time of 24 to 36 hours. On Wright-stained cytopreparations the cells are large, with round nuclei, multiple prominent nucleoli, and a small amount of basophilic cytoplasm with occasional azurophilic granules. Rare cells seem able to differentiate spontaneously to either recognizable neutrophils or eosinophils (1% to 2% in cultures unsupplemented with growth factors). Serial immunophenotypic flow cytometric analysis has consistently shown that the cells are CD20-, CD2-, CD34-, CD33+, CD13+, and weakly CD14+. It has consistently been found that a subpopulation (10% to 20%) of the cells are
Response of AMLI 4 Cells to Hematopoietic Growth Factors
In preliminary experiments, dose-response curves were established for cytokines (Fig I) . Concentrations of single cytokines causing approximately half maximum stimulation of proliferation were used in subsequent experiments. Cells were cultured at I X 10-5/mL in 25cm' tissue culture flasks alone or with 100 pmol/L GM-CSF, 250 pmol/L IL3, 0.4 n a m l IL-5, or combinations of these cytokines. Cultures receiving supplementation received medium containing the same concentration of the appropriate cytokine(s) at the time of medium replacement. Cultures were frequently evaluated by gross inspection, inverted microscopy, determination of viability by trypan blue dye exclusion, and light microscopic study of stained cytospin preparations. Differential counting included at least 200 cells per slide. Proliferation in response to cytokines was assessed by [3H]-thymidine incorporation, as previously described."
Analysis of Specific Binding of Cytokines
Biotin ylation of rh IL-5
RhIL-5 was extensively dialyzed against 0.1 mol/L Na2C03, pH 8.4, in preparation for biotinylation. One milligram of IL-5 was reacted with 80 pL NHS-biotin (Bio-Rad, Richmond, CA) in 1 mL of 0.1 mol/L Na2C03, pH 8.4, buffer for 4 hours in the dark at room temperature. The reaction was stopped by the addition of sufficient tris-glycine buffer to make 0.2 mol/L at pH 8.5. The resultant mixture was passed over a G-25 (PDIO) column. Elution and storage buffer used was 0.2 mol/L Tris-glycine, pH 8.5. Biotinylated IL-5 (b-IL-5) was assayed for bioactivity using the TF-I cell line" (gift of Dr T. Kitamura, DNAX, Palo Alto, CA). Activity was verified to be >70% of unlabeled rhIL-5.
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Flow Cytometric Analysis
AML14 cells were washed, and aliquots of 1 X IO6 were incubated for 30 minutes at 4°C in a minimum volume of Iscove's medium containing I% fetal bovine serum (FBS) and 2 pg b-IL5. The cells were then washed and reincubated for 30 minutes at 4°C with phycoerythrin-streptavidin in phosphate-buffered saline (PBS) containing 1% FBS. The cells were again washed and resuspended in 1 mL PBS containing 1% FBS and 0.01% sodium azide for analysis on a Becton-Dickinson (San Jose, CA) FACscan flow cytometer. Data were collected under logarithmic gain with photomultiplier thresholds set by unlabeled leukemic blast cells. To control for nonspecific binding, samples were run that were labeled with only phycoerythrinstreptavidin, or with b-IL-5 to which a 100-fold excess of unlabeled IL-5 had been added before second labeling.
GM-CSF and IL-3. Phycoerythrin-conjugated GM-CSF and IL-3 were obtained from R&D Systems, Inc, Minneapolis, MN, and were used according to the manufacturer's instructions. Briefly, 50 ng phycoerythrin-conjugated IL-5 or I L 3 was added to I X IO6 AMLI4 cells in a minimum volume ofbinding buffer. The cells were incubated for 60 minutes at 4"C, washed twice, and then analyzed. To control for nonspecific binding, samples were run that were labeled with streptavidin-phycoerythrin alone or with phycoerythrin-conjugated cytokine to which a 100-fold excess of unlabeled cyotkine had been added. In some experiments, it was determined whether cross-competition of binding of a fluorochrome-labeled cytokine by a different excess unlabeled cytokine occurred.
Detection of Cytokine Receptor mRNA
Total cellular mRNA was isolated from cells by guanidinium extraction followed by centrifugation in cesium chloride as previously For
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CACATAAATAGGT; which were derived from the published sequence of the IL5 receptor a-chain cDNA," beginning at position 545 and 982 ofthe coding region, respectively. IL-3 receptor a-chain: upper, S'CAACAGGCGTCAACAGTAT; lower, SCTTCTCAT-TTTCCAGTGCT; which were derived from the published sequence of the IL-3 receptor a-chain cDNA,14 beginning at position 429 and 672 of the coding region, respectively. GM-CSF receptor a-chain: upper, STCGCTCTTCCCTTCTCTCTGAT; lower, SCGTTC-CTATTTTCMTGTGTCC3'; which were derived from the published sequence of the GM-CSF receptor a-~hain,'~ beginning at position 121 and 779, respectively, of the entire cDNA sequence. Beta chain common to the IL-3, IL-5, and GM-CSF receptor: upper, SAAGGACAGCAAGACCGAGACCT; lower, SCCCCCAGCAGG-CAGACACAGGT; which were derived from the sequence as determined by Hayashida et all6 and stored in the GenBank database, beginning at position 1019 and 1753, respectively, of the sequence coding for the mature peptide.
Reverse transcriptase PCR was performed using the GeneAmp RNA PCR kit (Perkin Elmer Cetus, Norwalk, CT), following the manufacturer's instructions.
RESULTS
Effects of Growth Factor on AMLI 4 Cells
Significant dose-related augmentation of proliferation of AML14 cells was observed in response to GM-CSF (P < .00005), IL-5 (P < .00005), and to a lesser extent, IL-3 (P = .005). Combination of any two cytokines gave mixed results with only the combination of GM-CSF and IL-3, causing significantly more proliferation than any single cytokine (P = .OOl). The combination of IL-3 and IL-5 resulted in significantly more proliferation than either IL-3 or IL-5 alone (P = .OOOl) but was comparable with GM-CSF alone. The combination of GM-CSF and IL-5 resulted in less proliferation than was seen in response to GM-CSF alone (P = .OOO 1).
The combination of all three cytokines resulted in significantly more proliferation than was seen in response to any single cytokine or combination of any two cytokines (P < .Owl) (Fig 2) . Consistent results were obtained in three separate experiments.
Although only rare AML I4 cells exhibit morphologic differentiation in unsupplemented suspension cultures, GM-CSF, IL-3, and IL-5 caused obvious eosinophilic differentiation of AML14 cells, readily apparent by Wright staining and confirmed by Lux01 fast blue staining (Fig 3) . The differentiative response to a single cytokine was modest (about 10% of cells), and was similar for each of the three cytokines. (Table 1) . Little or no tendency was seen for augmented differentiation of AML 14 cells along macrophage or neutrophil lineages with any single cytokine or combination. Attempts to assess colony formation by AML14 cells in semisolid medium were unsuccessful, as the cells would invariably overgrow the culture plate after only 5 to 6 days, regardless of cytokine supplementation.
Assessment of Cytokine Binding
Flow cytometric analysis demonstrated clear binding of labeled IL-5 and GM-CSF to AML14 cells. Specificity of binding was demonstrated in each case by competitive inhibition by excess unlabeled cytokine (Fig 4) . It was not possible to demonstrate IL-3 binding by flow cytometry (data not shown).
Cross-competition of cytokines for receptors could be demonstrated by flow cytometry in some instances. IL-5 was able partially to compete for GM-CSF binding, and GM-CSF could partially compete for IL-5 binding. Although IL-3 binding could not be directly detected by flow cytometry, partial inhibition of IL-5 binding by IL-3 was seen (Fig 4) . IL-3 was not found to inhibit GM-CSF binding (data not shown), contrary to observations by other investigators in different cell populations. 17-19 Addition of 100 molar excess of irrelevant cytokines ( I L 1 or G-CSF) did not inhibit binding of either IL-5 or GM-CSF to AML14 cells (data not shown).
Expression of Cytokine Receptor mRNA by AML14 Cells
The presence of mRNA for the a-chains of the GM-CSF, IL-5, and IL-3 receptor was easily demonstrable in AML14 cells by reverse transcriptase PCR, as was mRNA for the pchain common to all three receptors (Fig 5) . ." 
DISCUSSION
Fresh leukemic cells and cell lines established from patients with AML are often capable of specifically binding and responding to hematopoietic growth factors by proliferation or differentiation. Although three cytokines, GM-CSF. IL-3, and IL-5, have been identified that are capable of promoting the growth and differentiation of normal eosinophil progenitors.l. 3.20 eosinophilic differentiation of AML cells in response to cytokines is unusual. IL-3 and GM-CSF are multilineage growth factors. whereas IL-5 is thought to act specifically as an eosinophil growth promoter on myeloid progenitors. Leukemic cells demonstrating differentiation in response to GM-CSF or IL-3 usually do so along the neutrophilic or macrophage lineages.
Recently, several studies of effects of IL-5 on AML cells were reported. IL-5 has been shown by us and other investigators to have proliferative2' and differentiative2',22 effects on fresh myeloid leukemic blast cells from some patients. We found fresh leukemic cells from a patient with the M4Eo variant of AML [del( 16)(q22)] to exhibit apparent differentiation to macrophages rather than eosinophils in response to IL-5." This observation was unexpected given the association of this subtype of AML with dysplastic marrow e~sinophilia~"'~ thought to be derived from the leukemic clone. Others have described IL-5-induced eosinophilic differentiation of fresh leukemic blasts from two patients, each of whom had the (8;2 I ) chromosomal translocation." A continuous leukemic cell line with the (8;2 1) translocation has been established but was found to be unresponsive to IL-5.5
A continuous cell line was recently established from a patient with M4Eo leukemia." Although the cell line maintained the inv( I6)(p I3q22) cytogenetic abnormality of the fresh cells, no response of this cell line to IL-5 could be demonstrated. Other continuous leukemic cell lines have occasionally been shown to express IL-5 receptors" or even to be dependent on IL-5 for but eosinophilic differentiation has not occurred.
Eosinophilic differentiation has been induced in occasional leukemic cell lines, such as that reported when a subclone of the HL-60 cell line is cultured in alkaline medium and then exposed to butyric acid.' These events, as in other situations in which differentiation induction occurs following exposure to nonbiological substances such as dimethyl sulfoxide or phorbol esters? may be poorly representative of physiologic mechanisms. Recently, a subline of the HL-60 promyelocytic leukemia cell line that spontaneously demonstrates eosinophilic differentiation2* was found to exhibit augmented eosinophilic differentiation (assessed by Luxol fast blue staining) in response to GM-CSF and IL-5 but not IL-3, which only augmented proliferation. Each of the three cytokines were also found to incrcasc dcgranulation, O2 production, and phagocytic ability of the cells. The effect of combinations of the cytokines on proliferation or differentiation was not reported. ' Although it is thought that IL-5 may be the major eosinophil~poietin,~~~~" there is also substantial evidence that IL-5 is a late-acting cytokine that demonstrates maximum activity when acting on an eosinophil progenitor pool expanded by an earlier-acting, multipotential cytokine such as IL-3 or GM-CSF.Z. For personal use only. on November 11, 2017. by guest www.bloodjournal.org From consistent with a cooperative model of cytokine interaction in induction of maximum eosinophil numbers.
It is now known that the cellular receptors for IL-3, IL-5, and GM-CSF are multimeric and have unique a-chains but share a common @ -~h a i n . l~-'~ Cross-competition of the three cytokines for their respective receptors has been well documerited, 14,18,I9,3 1 3 2 but is of uncertain biological significance. The AML14 cell line expresses mRNA for the a-chains of each of the three cytokine receptors and the @-chain common to all three. In addition, specific binding of GM-CSF and IL-5 to AMLl4 cells can be readily assessed by flow cytometry, although we could not detect IL-3 binding by this method. However, expression of functional IL-3 receptors at a density below the threshold for detection by flow cytometry can be reasonably assumed based on mRNA expression and observable biological effects on the cells of IL-3 alone and in cooperation with other cytokines. Cross-competition of cytokines for receptors was demonstrable on AML14 cells by flow cytometry, but we could not demonstrate inhibition of GM-CSF binding by IL-3. Although this is contrary to findings in several ~tudies,''-'~ it has been found that inhibition of GM-CSF binding by IL-3 does not occur on some cells that express GM-CSF receptors but not IL-3 receptors, whereas cross-competition is observed on cells expressing both receptor^.^'.^* It is possible that there is a spatial arrangement of GM-CSF and IL-3 receptor chain components that is necessary for cross-competition to be observed,14 and that the apparent low-density expression of IL-3 receptors on AML 14 cells results in the inability to detect IL-3 inhibition of GM-CSF binding.
Because cooperative effects of IL-3, IL-5, and GM-CSF on AML14 cell proliferation and differentiation can be demonstrated and can be assessed by relatively simple methodology, the AML14 cell line should be a useful model for the study of the interaction of the three cytokines and their receptors in the promotion of eosinophil progenitor proliferation and differentiation.
